The largest database of trusted experimental protocols

22 protocols using azd0530

1

Evaluating Combination Therapies on Ovarian Cancer Xenografts

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal work adhered to the Agency for Science, Technology and Research (A*STAR; Singapore), Institutional Animal Care and Use Committee (IACUC) guidelines on the use and handling of animals. SKOV3-Luc-D3 cells (Xenogen Co., Alameda, CA, USA) at a density of 3.5×106 in 100 μl of PBS were injected into the intraperitoneal cavity of 4-week-old female BALB/c nude mice. At 6 weeks post-implantation, the mice were randomly divided into control and treatment groups (n = 5 animals per group). For the treatment group, mice were administered via oral gavage with 50 mg/kg AZD0530, 50 mg/kg BIBF1120, or 25 mg/kg AZD0530 plus 25 mg/kg BIBF1120 (Selleck Chemicals, Houston, TX) for 5 days a week for 2 weeks. The drug was re-suspended in 0.5% hydroxypropyl methycellulose (Sigma-Aldrich) and 0.1% polysorbate buffer (Sigma-Aldrich). The control group received the vehicle buffer alone. The growth of tumor xenografts was monitored by bioluminescence using the IVIS system 2000 series (Xenogen Co.). The xenografts were harvested at 8 weeks post-implantation for gene expression microarray analysis (Affymetrix GeneChip Human Gene 1.0ST Array, Santa Clara, CA, USA) to ascertain the EMT scores, and then subjected to paraffin embedding followed by immunohistochemical staining for E-cadherin (#3195S, Cell Signaling Technology, Beverly, MA).
+ Open protocol
+ Expand
2

MCF-10A-ER-Src Cell Transformation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCF-10A-ER-Src cells (Iliopoulos et al., 2009 (link); Iliopoulos et al., 2010 (link); Ji et al., 2018 (link); Ji et al., 2019 (link)) were grown in DMEM/F12 without phenol red (Thermo Fisher Scientific, 11039–047) + 5% charcoal stripped FBS (Sigma, F6765) + 1% pen/strep (Thermo Fisher Scientific, 15140122) + 20 ng/ml EGF (Peprotech, AF-100–15) + 0.5 μg/ml Hydrocortisone (Sigma, H-0888) + 0.1 μg/ml cholera toxin (Sigma, C-8052) + 10 μg/ml insulin (Sigma, 10516). 1–0.4 μM Tamoxifen (Sigma, H7904) + 2–4 μM AZD0530 (Selleck Chemicals, S1006) were used to induce the transformation. MDA-MB-231 cells were grown in DMEM (Thermo Fisher Scientific, 11995–073) + 10% FBS (Sigma, TMS-013-B) + 1% pen/strep.
+ Open protocol
+ Expand
3

siRNA Transfection and Tamoxifen/AZD0530 Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded for 24 h and then transfected with siRNAs, 50 nM (Dharmacon) and Lipofectamine RNAiMax (Life Technologies). siRNA sequences were in Supplementary Data 3. After 24 h, cells were split and treated with either ethanol or Tamoxifen (0.4 µM, Sigma-Aldrich, H7904) plus AZD0530 (0.4 nM, Selleck Chemicals, S1006) for 24 h. Total RNA was isolated using mRNeasy Mini Kit (Qiagen, No. 217004). Two microgram RNA was used for SYBR Green based. Primers were listed in Supplementary Data 4.
+ Open protocol
+ Expand
4

AZD0530 Biochemical Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
AZD0530 was purchased from Selleck Chemicals and dissolved in dimethyl sulfoxide (DMSO) as a stock solutions of 10 mg/ml, then stored at −20°C. The anti-β-actin, anti-STAT3, anti-p-STAT3, anti-SRC and p-SRC antibodies were bought from Abcam, the anti-B cell lymphoma-2 (Bcl-2) antibody was purchased from Signalway Antibody and the SABC Immunohistochemistry assay kit was provided by Abcam.
+ Open protocol
+ Expand
5

Breast and Prostate Cancer Cell Lines Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
HCC1569 and BT549 breast cancer cells, and androgen-independent prostate PC3 cancer cells (American Type Culture Collection; Manassas, VA, USA) were maintained in RPMI1640 (Invitrogen, Carlsbad, CA, USA). NSCLC A549 cancer cells was maintained in DMEM (Invitrogen, Carlsbad, CA, USA) supplemented with 10 % fetal bovine serum (FBS; Gemini Bio-Products, West Sacramento, CA, USA) USA), and 1% Penicillin/Streptomycin/Glutamine (P/S/Glu) (Invitrogen, Carlsbad, CA, USA).
For drug treatments, both in validation and MEMA experiments, cells were cultured as above for 2 hr after initial adhesion, and were then treated with Lap (1.5 μM, LC Laboratories, Woburn, MA, USA) in media supplemented with 1 % FBS and 1 % P/S/Glu for additional 48 hr. Other pharmaceutical modulators were concurrently added: i.e. Verteporfin (VP, Sigma-Aldrich, St. Louis, MO, USA) was added at 2 μg/mL; and AZD0530 (Selleckchem, Houston, TX, USA) was added at 1 μM. All cell lines were authenticated by DNA Diagnostics Center.
+ Open protocol
+ Expand
6

Cell-based Assay Compound Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Palbociclib was obtained from Apexbio (Houston TX). Afatinib, AZD0530, RDEA11, AZD4054 and AZD2014 were obtained from Selleckchem (Houston, TX). Compounds were dissolved in DMSO, before dilution in cell culture media for cell-based assays.
+ Open protocol
+ Expand
7

HGF-Induced EMT in NBT-II Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
EMT induction with HGF and inhibitory effects of selected compounds were validated by NBT-II epithelial colony time-lapse microscopy. NBT-II cells were plated onto 12-well plate (BD) at a low density of 200 cells per well in 2 ml of medium. Cells were allowed to grow and form epithelial colonies for a period of 4 days. The cultures were then refreshed with medium containing with or without 5 ng/ml HGF or compound 2 µM AZD0530 (Selleck Chemicals) prior to time-lapse imaging. Time-lapse microscopy of individual cell colonies was performed using a video microscope incubator system (Axiovert-200M, Carl Zeiss). Time-lapse images were taken at 5 min intervals for 24 h. Tracking of cells was performed with the particle tracking function in Metamorph software (Metamorph).
+ Open protocol
+ Expand
8

Molecular Mechanisms in Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies against the 5-HT7 receptor (5-hydroxytryptamine receptor 7), MMP9 (matrix metallopeptidase 9), PCNA (proliferating cell nuclear antigen), and survivin (baculoviral IAP repeat-containing protein 5) were purchased from Proteintech Group, Inc. (Wuhan, Hubei, China), while phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204), p44/42 MAPK (Erk1/2), phospho-SAPK/JNK (Thr183/Tyr185), SAPK/JNK, phospho-p38 MAPK (Thr180/Tyr182), p38 MAPK, phospho-Akt (Ser473), Akt (pan), phospho-Src (Ser17), and Src antibodies were purchased from Cell Signaling Technology Inc. (Beverly, MA, USA), and the β-actin antibody was obtained from Sungene Biotech Co, Ltd (Tianjin, China). LP211 was purchased from MedChemExpress LLC (Monmouth Junction, NJ, USA). BMS582949, MK2206, SP600125 and AZD0530 were obtained from Selleck Chemicals LLC (Houston, TX, USA).
+ Open protocol
+ Expand
9

Inhibitor Compounds for Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Src inhibitor AZD0530 (catalog no. S1006) was purchased from Selleck, USA. SGK1 inhibitor (catalog no. RGNCY-0058) was purchased from Reagency (Vic, Australia). Rapamycin (catalog no. R0395), PP2 (catalog no. P0042), Verteporfin (catalog no. SML0534) and DAPI (1:500, catalog no. D9542) were purchased from Sigma. MEK inhibitor Trametinib (catalog no. HY-10999) was purchased from MedChem Express (Monmouth Junction, NJ).
+ Open protocol
+ Expand
10

Cell Culture Conditions for Transitional Carcinoma Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The transitional carcinoma cell lines NBT-II, T24, J82, UMUC3 and human embryonic kidney cells HEK293T were obtained from the American Type Culture Collection (ATCC; catalogue no. CRL-1655 and CRL-1749). Cells were routinely cultured in Dulbecco’s modified eagle medium (DMEM, Gibco, Life Technologies) supplemented with 10% fetal bovine serum (FBS, HyClone Thermo Scientific), and 100 units/ml penicillin–streptomycin (1 × pen–strep, Invitrogen). Cultured cells were regularly tested for mycoplasma contamination. Cells were grown in a 5% CO2 atmosphere incubator at 37 °C. When appropriate HGF (5 ng/ml, Calbiochem), TGF-β1 (2.5 ng/ml, R&D), SB431542 (5 μM, Tocris), A83-01 (8 μM, Tocris), A83-01 is a small molecule inhibitor specifically targeting TβRI (ALK5), Activin receptor type-1B/ALK4 and Activin receptor type-A/ALK-7, the three of which contain highly structurally related kinase domains, PD0325901 (1 μM, Selleck Chemicals), LY2157299 (1 μM, Selleck Chemicals), AZD0530 (2 µM, Selleck Chemicals), JNJ38877605 (4 µM, Selleck Chemicals) or MG132 (2 μM; Sigma) was added. All cell lines were independently genotyped and validated (please refer to source data).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!